Chugai Pharmaceutical Co. Ltd. | Mutual Funds
Mutual Funds that own Chugai Pharmaceutical Co. Ltd.
Vanguard Health Care Fund
15,610,000
2.79%
0
1.8%
06/30/2018
Nomura Asset NIKKEI 225 Index ETF (1321)
9,444,000
1.69%
128,000
1.06%
07/31/2018
American Funds EuroPacific Growth Fund
5,818,000
1.04%
0
0.24%
06/30/2018
Nikko Asset Listed Index 225 ETF (1330)
4,790,000
0.86%
2,000
1.04%
08/20/2018
Daiwa Asset NIKKEI 225 ETF (1320)
4,228,000
0.76%
-16,000
1.04%
07/31/2018
Nomura Asset TOPIX ETF Fund (1306)
3,292,500
0.59%
52,100
0.27%
07/31/2018
Vanguard Total International Stock Index Fund
3,061,903
0.55%
32,700
0.05%
07/31/2018
Government Pension Fund - Global (The)
2,436,817
0.44%
-823,601
0.02%
12/31/2017
Mitsubishi UFJ MAXIS Nikkei 225 ETF (1346)
2,294,000
0.41%
46,000
1.04%
07/31/2018
T Rowe Price International Stock Fund
2,100,900
0.38%
-53,600
0.82%
06/30/2018
| Address |
Nihonbashi Mitsui Tower, 15/F
Tokyo Tokyo 103
Japan
|
|
Employees
|
- |
| Website |
http://www.chugai-pharm.co.jp |
| Updated |
07/08/2019 |
| Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of the pharmaceuticals. Its operations are carried out through the following business divisions: Research, Development, Production, Marketing, Medical Affairs and Drug Safety. The Research division focuses its efforts on creating innovative drugs by using its competitive strengths that include proprietary antibody technologies and cutting-edge research resources. |
